Evidence map›Paper›PMID 29940944›Full record

ArticleBMC structural biology2018

Structure and dynamics of a human myelin protein P2 portal region mutant indicate opening of the β barrel in fatty acid binding proteins.

Saara Laulumaa, Tuomo Nieminen, Arne Raasakka, Oda C Krokengen, Anushik Safaryan, Erik I Hallin, Guillaume Brysbaert, Marc F Lensink, Salla Ruskamo, Ilpo Vattulainen and 1 more

Abstract read
In one paragraph

Article in BMC structural biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Fatty acid-binding proteins: functional understanding and diagnostic implications.Current opinion in clinical nutrition and metabolic care · 2019
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Saara LaulumaaFaculty of Biochemistry and Molecular Medicine, University of Oulu, Oulu, Finland.
Tuomo NieminenDepartment of Physics, Tampere University of Technology, Tampere, Finland.
Arne RaasakkaDepartment of Biomedicine, University of Bergen, Bergen, Norway.
Oda C KrokengenDepartment of Biomedicine, University of Bergen, Bergen, Norway.
Anushik SafaryanDepartment of Biomedicine, University of Bergen, Bergen, Norway.
Erik I HallinDepartment of Biomedicine, University of Bergen, Bergen, Norway.
Guillaume BrysbaertUnité de Glycobiologie Structurale et Fonctionnelle, University of Lille, CNRS UMR8576 UGSF, F-59000, Lille, France.
Marc F LensinkUnité de Glycobiologie Structurale et Fonctionnelle, University of Lille, CNRS UMR8576 UGSF, F-59000, Lille, France.
Salla RuskamoFaculty of Biochemistry and Molecular Medicine, University of Oulu, Oulu, Finland.
Ilpo VattulainenDepartment of Physics, Tampere University of Technology, Tampere, Finland.
Petri KursulaFaculty of Biochemistry and Molecular Medicine, University of Oulu, Oulu, Finland. petri.kursula@uib.no.ORCID 0000-0001-8529-3751

Funding

Academy of Finland (FI) 275225Academy of Finland (FI) 307415European Research Council 290974
6 · The paper itself

Abstract

backgroundMyelin is a multilayered proteolipid sheath wrapped around selected axons in the nervous system. Its constituent proteins play major roles in forming of the highly regular membrane structure. P2 is a myelin-specific protein of the fatty acid binding protein (FABP) superfamily, which is able to stack lipid bilayers together, and it is a target for mutations in the human inherited neuropathy Charcot-Marie-Tooth disease. A conserved residue that has been proposed to participate in membrane and fatty acid binding and conformational changes in FABPs is Phe57. This residue is thought to be a gatekeeper for the opening of the portal region upon ligand entry and egress.

resultsWe performed a structural characterization of the F57A mutant of human P2. The mutant protein was crystallized in three crystal forms, all of which showed changes in the portal region and helix α2. In addition, the behaviour of the mutant protein upon lipid bilayer binding suggested more unfolding than previously observed for wild-type P2. On the other hand, membrane binding rendered F57A heat-stable, similarly to wild-type P2. Atomistic molecular dynamics simulations showed opening of the side of the discontinuous β barrel, giving important indications on the mechanism of portal region opening and ligand entry into FABPs. The results suggest a central role for Phe57 in regulating the opening of the portal region in human P2 and other FABPs, and the F57A mutation disturbs dynamic cross-correlation networks in the portal region of P2.

conclusionsOverall, the F57A variant presents similar properties to the P2 patient mutations recently linked to Charcot-Marie-Tooth disease. Our results identify Phe57 as a residue regulating conformational changes that may accompany membrane surface binding and ligand exchange in P2 and other FABPs.

Indexed as

MutationCalorimetry, Differential ScanningCharcot-Marie-Tooth DiseaseCrystallography, X-RayFatty AcidsHumansLipid BilayersModels, MolecularMolecular Dynamics SimulationMyelin P2 ProteinPhenylalanineProtein Structure, SecondaryProtein UnfoldingFatty AcidsLipid BilayersMyelin P2 ProteinPhenylalaninePMP2 protein, humanCrystal structureFatty acid-binding proteinMembrane bindingMolecular dynamicsMutationMyelinProtein stability

Identifiers

PMID29940944
PMCPMC6020228

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.